Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K0706 in Early Parkinson's Disease
NCT03655236Phase 2Terminated
- Sponsor
- Sun Pharma
- Start
- Feb 2019
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of vodobatinib in Parkinson's disease (PD), sponsored by Sun Pharma. Started Feb 2019; status: terminated.
02
Drugs
vodobatinib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03655236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655236.